Minor segmental wall motion abnormalities detected in patients with Chagas' disease have adverse prognostic

A Pazin-Filho1, M M D Romano, O C Almeida-Filho

  • 1Divisão de Cardiologia, Departamento de Clínica Médica, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.

Insights

Mild left ventricular abnormalities in Chagas' disease patients predict worsening systolic function. Early detection of these wall motion abnormalities is crucial for monitoring Chagas' disease progression.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Echocardiography

Background:

  • Chagas' disease can impair left ventricular contractility, even in early stages.
  • Two-dimensional echocardiography reveals subtle wall motion abnormalities in some patients.
  • The prognostic significance of these early echocardiographic findings remains unclear.

Purpose of the Study:

  • To investigate the prognostic implications of mild baseline left ventricular wall motion abnormalities.
  • To determine if these abnormalities predict future deterioration of global systolic function in Chagas' disease patients.
  • To assess the association between mild segmental abnormalities and worsening cardiac function.

Main Methods:

  • Retrospective analysis of 59 Chagas' disease patients with normal baseline global systolic function.
  • Categorization into Group 1 (mild baseline wall motion abnormalities) and Group 2 (no abnormalities).
  • Longitudinal follow-up using echocardiography to monitor changes in global left ventricular systolic function.

Main Results:

  • Global left ventricular systolic function deteriorated in 71.4% of Group 1 patients versus 22.2% in Group 2 (P < 0.005).
  • Mild segmental left ventricular wall motion abnormalities were significantly associated with worsening systolic function.
  • Age and follow-up duration were not independent predictors of functional decline.

Conclusions:

  • Mild segmental left ventricular wall motion abnormalities are a significant predictor of systolic function deterioration in Chagas' disease.
  • These findings highlight the prognostic value of subtle echocardiographic changes in managing Chagas' disease.
  • Early identification of wall motion abnormalities can aid in risk stratification and patient monitoring.

Related Concept Videos

American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...